Kevin E Lofton
CIK 1468818 · last filed 2026-10-21
Kevin E Lofton is a corporate insider who has filed 94 SEC Form 4 insider transactions across 5 companies since 2009. The most recent filing, for MDT, was dated Oct 21, 2026. Across all open-market trades the lifetime net is −$286.9K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $17.5M across reported positions. 76 SEC filings were submitted jointly with GILEAD SCIENCES, INC.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
GILD price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
710 MEDTRONIC PARKWAY
MINNEAPOLIS, MN 55432
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MDT | Director | 9,977 | $94.79 | $945.7K | $0 | 8 | 2026-10-21 |
| MMEDV | Director | 40,409 | — | — | $0 | 2 | 2026-10-19 |
| MMED | Director | 27,778 | $18.66 | $518.3K | $0 | 1 | 2026-03-11 |
| GILD | Director | 101,095 | $158.69 | $16.04M | -$286.9K | 74 | 2024-03-29 |
| RITE AID CORP (RAD) Delisted | Director | 46,193 | $0.65 | $29.9K | $0 | 9 | 2021-07-09 |
Recent Filings
94 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-10-21 | MDT | Other (J) | −182 | $0 | EDGAR |
| 2026-10-19 | MMEDV | Grant (A) | +836 | $0 | EDGAR |
| 2026-10-13 | MMEDV | Grant (A) | +11,795 | $0 | EDGAR |
| 2026-04-29 | MDT | Mixed | +1,904 | -$17.0K | EDGAR |
| 2026-03-11 | MMED | Grant (A) | +27,778 | $0 | EDGAR |
| 2025-04-30 | MDT | Mixed | +1,867 | $156.8K | EDGAR |
| 2024-05-03 | MDT | Tax (F) | −192 | -$15.5K | EDGAR |
| 2024-05-01 | MDT | Grant (A) | +2,165 | $175.1K | EDGAR |
| 2024-03-29 | GILD | Grant (A) | — | $0 | EDGAR |
| 2023-12-29 | GILD | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.